Chlorhexidine and octenidine susceptibility of bacterial isolates from clinical samples in a three-armed cluster randomised decolonisation trial

PLoS One. 2022 Dec 14;17(12):e0278569. doi: 10.1371/journal.pone.0278569. eCollection 2022.

Abstract

Background: Routine use of chlorhexidine or octenidine for antiseptic bathing may have unintended consequences. Our analysis aimed to assess the phenotypic susceptibility of bacterial isolates from clinical samples to chlorhexidine and octenidine collected from intensive care units (ICU) that routinely used 2% chlorhexidine-impregnated wash cloths or 0.08% octenidine wash mitts (intervention) or water and soap (control) for daily patient care.

Methods: This study was conducted within the context of a three armed cluster-randomised controlled decolonisation trial (Registration number DRKS00010475, registration date August 18, 2016). Bacterial isolates were collected prior to and at the end of a 12-month-intervention period from patients with ≥ 3 days length of stay at an ICU assigned to one of two intervention groups or the control group. Phenotypic susceptibility to chlorhexidine and octenidine was assessed by an accredited contract research laboratory determining minimal inhibitory concentrations (MIC) as percentage of extraction solutions used. MIC were reported as estimated concentrations in μg/ml derived from the chlorhexidine and octenidine extraction solutions. Statistical analyses including generalized estimating equation models were applied.

Results: In total, 790 ICU-attributable bacterial isolates from clinical samples (e.g. blood, urine, tracheal aspirate) were eligible for all analyses. Pathogens included were Staphylococcus aureus (n = 155), coagulase-negative staphylococci (CoNS, n = 122), Escherichia coli (n = 227), Klebsiella spp. (n = 150) and Pseudomonas aeruginosa (n = 136). For all species, chlorhexidine and octenidine MIC did not increase from baseline to intervention period in the antiseptic bathing groups. For proportions of bacterial isolates with elevated chlorhexidine / octenidine MIC (≥ species-specific chlorhexidine / octenidine MIC50), adjusted incidence rate ratios (aIRR) showed no differences between the intervention groups and the control group (intervention period).

Conclusion: We found no evidence for reduced phenotypic susceptibilities of bacterial isolates from clinical samples to chlorhexidine or octenidine in ICUs 12 months after implementation of routine antiseptic bathing with the respective substances.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Infective Agents, Local* / pharmacology
  • Chlorhexidine* / pharmacology
  • Humans
  • Imines / pharmacology
  • Intensive Care Units
  • Pyridines / pharmacology

Substances

  • Chlorhexidine
  • octenidine
  • Imines
  • Anti-Infective Agents, Local
  • Pyridines

Grants and funding

This study was funded by the German Federal Ministry of Education and Research within the scope of the InfectControl consortium (Grant No. 03ZZ0807A) awarded to PG. Sage Products / Stryker and Schülke, funded the (antiseptic) products for the intervention and supported the investigation of tolerances to chlorhexidine and octenidine by an independent accredited contract laboratory. Dr. Brill + Partner GmbH was the independent contract-laboratory assigned by Schülke and Stryker /Sage to conduct the investigations of tolerances to chlorhexidine and octenidine (by minimum inhibitory concentration testing). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.